Oligonucleotide · Discovery
Monomer & Ligand
Our team has extensive experience with 1,000+ customized amidite molecules with most challenging structures, to support your oligonucleotide discovery projects. Additionally, we offer 500+…

Amidite Synthesis
Our team has extensive experience with 1,000+ customized amidite molecules with most challenging structures, to support your oligonucleotide discovery projects. Additionally, we offer 500+ amidite catalog products readily available.
Visit Amidite Catalog e-Shop
We are experienced in various modifications:
- 2’/3’/4’ modification with GalNAc moiety, lipid, amine, alkyne
- Sugar Skeleton Modification: bicyclic sugar, aza/thio sugar, acyclic sugar
- Base Modification: 7-deaza A/G, Pseudo U (pU), N-Me pU
- Therapeutic RNA Modifications (2’-OMe, 2’-F, 2’-O-MOE)
- Phosphorus Backbone Modification: PACE, thiophosphoramidite, MeP, EtP
- Base Protecting Alternative (Bz, Ac, iBu, pac/iPr-pac, O-NPE, etc.)
- Functional / Conjugate Modifiers (phosphate reagents, amino & thiol linkers, spacers, cholesterol, dye, etc.)
Sample Amidite Molecules

RNAi-Amidite
(2′-F, OMe Moe, OTBS, etc.)

LNA Amidite

TNA Amidite

Vpm-POM

DNA C(Bz) Amidite

PACE Amidite

Thio-Amidite

PMO Monomer
GalNAc Synthesis
N-Acetylgalactosamine (GalNAc) is an amino sugar derivative of galactose. Conjugation with GalNAc represents an efficient method for enhancing siRNA target organ accumulation and facilitating cellular uptake.
Our team has extensive experience synthesizing over 100 types of GalNAc molecules, including Mono-GalNAc, Tri-GalNAc, Tetra-GalNAc, GalNAc amidite, GalNAc PFP ester, GalNAc N 3, and GalNAc-PEG conjugates, among others.
With more than 100 GalNAc building blocks and CPG/PS conjugate resins, we are well positioned to accelerate your GalNAc-oligonucleotide discovery projects.



Overcome GalNAc synthesis challenges
There are many synthetic challenges for GalNAc because most of the intermediates are oily or foamy solids. The synthesis involves many columns and prep-HPLC purification steps, resulting scale-up difficulties and low yields. Analytical method for GalNAc synthesis is also challenging due to low UV response, complex impurity profile and poor stability.

Original Process
Oil Intermediates

Modified Process
Solid Intermediates
Enabled by strong chemistry platform, WuXi TIDES developed convergent routes through telescoping processes without column purification steps. The isolated intermediates were stable solids. We applied the precipitation process and/or spray drying process to reduce the needs for the columns and prep-HPLC steps. Our analytical teams identified many GalNAc-related impurities to support method development and release testing.
Why WuXi TIDES
What this platform adds
Scalability
From discovery to commercialisation entirely within WuXi TIDES, with readily available large R&D and manufacturing capacity.
Conjugation Chemistry
Seamless collaboration across the oligonucleotide, peptide and small molecule teams — the conjugates nobody else wants to touch.
New Technology
Biocatalysis for gRNA synthesis, thin film evaporation, reactor-in-series with PAT, continuous flow chromatography, TFF.
Global Quality Standard
One quality system across every site, approved by the major regulatory agencies around the world.
Comprehensive Analytical
Method development and validation, IPC and release testing, characterisation and stability under one roof.
Integrated CMC
API and formulation development, manufacturing, analytical, dossier preparation and clinical supply as a single programme.
Meeting global quality standards
Inspection record
How can we help?
Our TIDES drug experts stand ready.
Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.
Small molecule projects? WuXi STA